• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钠/氢交换体1,一种治疗心肌肥厚和心力衰竭的潜在药物靶点。

Na/H Exchanger 1, a Potential Therapeutic Drug Target for Cardiac Hypertrophy and Heart Failure.

作者信息

Xia Huiting, Zahra Aqeela, Jia Meng, Wang Qun, Wang Yunfu, Campbell Susan L, Wu Jianping

机构信息

School of Chemistry, Chemical Engineering and Life Sciences, Wuhan University of Technology, Wuhan 430070, China.

Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.

出版信息

Pharmaceuticals (Basel). 2022 Jul 15;15(7):875. doi: 10.3390/ph15070875.

DOI:10.3390/ph15070875
PMID:35890170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9318128/
Abstract

Cardiac hypertrophy is defined as increased heart mass in response to increased hemodynamic requirements. Long-term cardiac hypertrophy, if not counteracted, will ultimately lead to heart failure. The incidence of heart failure is related to myocardial infarction, which could be salvaged by reperfusion and ultimately invites unfavorable myocardial ischemia-reperfusion injury. The Na/H exchangers (NHEs) are membrane transporters that exchange one intracellular proton for one extracellular Na. The first discovered NHE isoform, NHE1, is expressed almost ubiquitously in all tissues, especially in the myocardium. During myocardial ischemia-reperfusion, NHE1 catalyzes increased uptake of intracellular Na, which in turn leads to Ca overload and subsequently myocardial injury. Numerous preclinical research has shown that NHE1 is involved in cardiac hypertrophy and heart failure, but the exact molecular mechanisms remain elusive. The objective of this review is to demonstrate the potential role of NHE1 in cardiac hypertrophy and heart failure and investigate the underlying mechanisms.

摘要

心脏肥大被定义为心脏质量增加以应对血流动力学需求增加。长期的心脏肥大如果不加以对抗,最终将导致心力衰竭。心力衰竭的发生率与心肌梗死有关,心肌梗死可通过再灌注挽救,但最终会引发不利的心肌缺血-再灌注损伤。钠/氢交换体(NHEs)是一种膜转运蛋白,可将一个细胞内质子与一个细胞外钠离子进行交换。最早发现的NHE亚型NHE1几乎在所有组织中广泛表达,尤其是在心肌中。在心肌缺血-再灌注期间,NHE1催化细胞内钠离子摄取增加,进而导致钙超载并随后引发心肌损伤。大量临床前研究表明,NHE1参与心脏肥大和心力衰竭,但确切的分子机制仍不清楚。本综述的目的是阐述NHE1在心脏肥大和心力衰竭中的潜在作用,并研究其潜在机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1980/9318128/4efcd17a70f7/pharmaceuticals-15-00875-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1980/9318128/1746d67c662c/pharmaceuticals-15-00875-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1980/9318128/4efcd17a70f7/pharmaceuticals-15-00875-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1980/9318128/1746d67c662c/pharmaceuticals-15-00875-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1980/9318128/4efcd17a70f7/pharmaceuticals-15-00875-g002.jpg

相似文献

1
Na/H Exchanger 1, a Potential Therapeutic Drug Target for Cardiac Hypertrophy and Heart Failure.钠/氢交换体1,一种治疗心肌肥厚和心力衰竭的潜在药物靶点。
Pharmaceuticals (Basel). 2022 Jul 15;15(7):875. doi: 10.3390/ph15070875.
2
The Na(+)/H(+) exchanger: a target for cardiac therapeutic intervention.钠氢交换体:心脏治疗干预的一个靶点。
Curr Drug Targets Cardiovasc Haematol Disord. 2005 Aug;5(4):323-35. doi: 10.2174/1568006054553417.
3
The myocardial Na+/H+ exchanger: a potential therapeutic target for the prevention of myocardial ischaemic and reperfusion injury and attenuation of postinfarction heart failure.心肌钠氢交换体:预防心肌缺血再灌注损伤及减轻梗死后心力衰竭的潜在治疗靶点。
Drugs. 2001;61(3):375-89. doi: 10.2165/00003495-200161030-00006.
4
Regulation of the Na(+)/H(+) exchanger in the healthy and diseased myocardium.健康和患病心肌中钠氢交换体的调节
Expert Opin Ther Targets. 2009 Jan;13(1):55-68. doi: 10.1517/14728220802600707.
5
Regulation of the cardiac Na⁺/H⁺ exchanger in health and disease.心脏钠氢交换体在健康和疾病中的调节。
J Mol Cell Cardiol. 2013 Aug;61:68-76. doi: 10.1016/j.yjmcc.2013.02.007. Epub 2013 Feb 18.
6
The myocardial Na(+)-H(+) exchange: structure, regulation, and its role in heart disease.心肌钠氢交换体:结构、调节及其在心脏病中的作用
Circ Res. 1999 Oct 29;85(9):777-86. doi: 10.1161/01.res.85.9.777.
7
Overexpression of the Na+/H+ exchanger and ischemia-reperfusion injury in the myocardium.心肌中钠氢交换体的过表达与缺血再灌注损伤
Am J Physiol Heart Circ Physiol. 2007 May;292(5):H2237-47. doi: 10.1152/ajpheart.00855.2006. Epub 2007 Jan 5.
8
Activity of the Na(+)/H(+) exchanger is critical to reperfusion damage and preconditioning in the isolated rat heart.钠氢交换体的活性对于离体大鼠心脏的再灌注损伤和预处理至关重要。
Cardiovasc Res. 2000 Nov;48(2):244-53. doi: 10.1016/s0008-6363(00)00166-8.
9
The Na(+) /H(+) exchanger and pH regulation in the heart.心脏中的钠/氢交换体与pH调节
IUBMB Life. 2014 Oct;66(10):679-85. doi: 10.1002/iub.1323. Epub 2014 Oct 30.
10
Regulation and role of the presynaptic and myocardial Na+/H+ exchanger NHE1: effects on the sympathetic nervous system in heart failure.突触前和心肌钠氢交换体NHE1的调节及作用:对心力衰竭时交感神经系统的影响
Cardiovasc Drug Rev. 2007 Summer;25(2):123-31. doi: 10.1111/j.1527-3466.2007.00010.x.

引用本文的文献

1
Effects of SGLT2 inhibitors on ion channels in heart failure: focus on the endothelium.钠-葡萄糖协同转运蛋白2抑制剂对心力衰竭中离子通道的影响:聚焦于内皮细胞。
Basic Res Cardiol. 2025 May 14. doi: 10.1007/s00395-025-01115-y.
2
Naringin attenuates angiotensin II induced cardiac hypertrophy by inhibiting carbonic anhydrase II.柚皮苷通过抑制碳酸酐酶II减轻血管紧张素II诱导的心肌肥大。
Sci Rep. 2025 Apr 6;15(1):11789. doi: 10.1038/s41598-025-95537-2.
3
Inhibition of Sodium/Hydrogen Exchanger-1 in the Right Ventricle and Lung Dysfunction Induced by Experimental Pulmonary Arterial Hypertension in Rats.

本文引用的文献

1
Sodium-Glucose Co-transporter-2 Inhibitor of Dapagliflozin Attenuates Myocardial Ischemia/Reperfusion Injury by Limiting NLRP3 Inflammasome Activation and Modulating Autophagy.达格列净的钠-葡萄糖协同转运蛋白2抑制剂通过限制NLRP3炎性小体激活和调节自噬减轻心肌缺血/再灌注损伤。
Front Cardiovasc Med. 2022 Jan 10;8:768214. doi: 10.3389/fcvm.2021.768214. eCollection 2021.
2
Controlling Reperfusion Injury With Controlled Reperfusion: Historical Perspectives and New Paradigms.控制性再灌注防治再灌注损伤:历史观点与新范例。
J Cardiovasc Pharmacol Ther. 2021 Nov;26(6):504-523. doi: 10.1177/10742484211046674. Epub 2021 Sep 17.
3
抑制大鼠实验性肺动脉高压诱导的右心室钠/氢交换体-1与肺功能障碍
J Am Heart Assoc. 2025 Mar 18;14(6):e036859. doi: 10.1161/JAHA.124.036859. Epub 2025 Mar 7.
4
Molecular and metabolic landscape of adenosine triphosphate-induced cell death in cardiovascular disease.心血管疾病中三磷酸腺苷诱导的细胞死亡的分子和代谢图景
World J Cardiol. 2024 Dec 26;16(12):689-706. doi: 10.4330/wjc.v16.i12.689.
5
RSK1 and RSK2 as therapeutic targets: an up-to-date snapshot of emerging data.核糖體S6激酶1和核糖體S6激酶2作為治療靶點:新興數據的最新概述
Expert Opin Ther Targets. 2024 Dec;28(12):1047-1059. doi: 10.1080/14728222.2024.2433123. Epub 2024 Dec 4.
6
ALDH2 mediates the effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i) on improving cardiac remodeling.ALDH2 介导钠-葡萄糖共转运蛋白 2 抑制剂 (SGLT2i) 改善心脏重构的作用。
Cardiovasc Diabetol. 2024 Oct 26;23(1):380. doi: 10.1186/s12933-024-02477-8.
7
Impact of mechanical cues on key cell functions and cell-nanoparticle interactions.机械信号对关键细胞功能及细胞与纳米颗粒相互作用的影响。
Discov Nano. 2024 Jun 22;19(1):106. doi: 10.1186/s11671-024-04052-2.
8
Influence of acidic metabolic environment on differentiation of stem cell-derived cardiomyocytes.酸性代谢环境对干细胞源性心肌细胞分化的影响。
Front Cardiovasc Med. 2024 Mar 20;11:1288710. doi: 10.3389/fcvm.2024.1288710. eCollection 2024.
9
The Dysfunction of Ca Channels in Hereditary and Chronic Human Heart Diseases and Experimental Animal Models.钙通道在遗传性和慢性人类心脏疾病及实验动物模型中的功能障碍。
Int J Mol Sci. 2023 Oct 27;24(21):15682. doi: 10.3390/ijms242115682.
10
Astragaloside IV derivative HHQ16 ameliorates infarction-induced hypertrophy and heart failure through degradation of lncRNA4012/9456.黄芪甲苷衍生物 HHQ16 通过降解 lncRNA4012/9456 改善梗死诱导的心肌肥厚和心力衰竭。
Signal Transduct Target Ther. 2023 Oct 19;8(1):414. doi: 10.1038/s41392-023-01660-9.
Sodium Glucose Co-Transporter 2 Inhibitors Ameliorate Endothelium Barrier Dysfunction Induced by Cyclic Stretch through Inhibition of Reactive Oxygen Species.
钠-葡萄糖协同转运蛋白 2 抑制剂通过抑制活性氧改善周期性拉伸诱导的血管内皮屏障功能障碍。
Int J Mol Sci. 2021 Jun 3;22(11):6044. doi: 10.3390/ijms22116044.
4
Myocardial Impact of NHE1 Regulation by Sildenafil.西地那非对NHE1调节的心肌影响。
Front Cardiovasc Med. 2021 Feb 22;8:617519. doi: 10.3389/fcvm.2021.617519. eCollection 2021.
5
The electrogenic sodium bicarbonate cotransporter and its roles in the myocardial ischemia-reperfusion induced cardiac diseases.电致生钠碳酸氢盐协同转运蛋白及其在心肌缺血再灌注诱导的心脏疾病中的作用。
Life Sci. 2021 Apr 1;270:119153. doi: 10.1016/j.lfs.2021.119153. Epub 2021 Feb 1.
6
Matrix Metalloproteinases Repress Hypertrophic Growth in Cardiac Myocytes.基质金属蛋白酶抑制心肌细胞的肥大生长。
Cardiovasc Drugs Ther. 2021 Apr;35(2):353-365. doi: 10.1007/s10557-020-07138-y. Epub 2021 Jan 5.
7
Role of Genetic Mutations of the Na/H Exchanger Isoform 1, in Human Disease and Protein Targeting and Activity.钠/氢交换体 1 同工型的遗传突变在人类疾病及蛋白靶向和活性中的作用
Mol Cell Biochem. 2021 Feb;476(2):1221-1232. doi: 10.1007/s11010-020-03984-4. Epub 2020 Nov 17.
8
The study of myocardial ischemia-reperfusion treatment through computational modelling.通过计算建模对心肌缺血再灌注治疗的研究。
J Theor Biol. 2021 Jan 21;509:110527. doi: 10.1016/j.jtbi.2020.110527. Epub 2020 Oct 20.
9
Anti-hypertrophic effect of Na/H exchanger-1 inhibition is mediated by reduced cathepsin B.钠/氢交换体-1 抑制的抗肥厚作用是通过降低组织蛋白酶 B 介导的。
Eur J Pharmacol. 2020 Dec 5;888:173420. doi: 10.1016/j.ejphar.2020.173420. Epub 2020 Aug 8.
10
Pathophysiology of hepatic Na/H exchange (Review).肝脏钠/氢交换的病理生理学(综述)
Exp Ther Med. 2020 Aug;20(2):1220-1229. doi: 10.3892/etm.2020.8888. Epub 2020 Jun 12.